Venetoclax shows potential for R/R hairy cell leukemia

Published Date: 13 Mar 2023

Five out of six patients with relapsed or recurrent lymphoma responded to venetoclax alone or in combination with rituximab.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Spouses of Cancer Patients May Be at Increased Risk of Suicide

2.

Chemotherapy can be a challenging treatment?here's how to deal with some of the side-effects

3.

Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC

4.

Obesity-associated cancers may be on the rise in Puerto Rico

5.

Cancer patients want financial screening early in care, study finds


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot